Transfusion thresholds in acute coronary syndromes

Area of Science:

• Cardiology
• Hematology
• Clinical Evidence Synthesis

Background:

• Anemia is common in patients experiencing acute coronary syndromes (ACS).
• Significant uncertainty exists regarding the best approach for red blood cell transfusions in ACS patients.
• Current clinical practice guidelines show inconsistencies in transfusion management recommendations for anemia in ACS.

Purpose of the Study:

• To review existing clinical evidence on transfusion strategies for anemia in ACS.
• To summarize current clinical practice guidelines for managing anemia in ACS.
• To outline future research directions in this field.

Main Methods:

• Systematic review of randomized trials comparing transfusion strategies in ACS.
• Analysis of current clinical practice guidelines.
• Synthesis of evidence on short-term and long-term outcomes.

Main Results:

• Limited randomized trial data exist for restrictive versus liberal transfusion in ACS.
• Short-term outcomes show clinical equipoise between transfusion strategies.
• A trend suggests liberal transfusion may benefit long-term major adverse cardiac events, but evidence is insufficient.

Conclusions:

• More robust evidence is required to define optimal transfusion strategies for ACS.
• Harmonization of clinical practice guidelines is needed.
• Future research should investigate hemoglobin alternatives, functional outcomes, and post-discharge anemia management.